期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肾上腺素β受体阻滞药在慢性阻塞性肺疾病合并慢性心力衰竭患者中的应用 被引量：7

Beta-adrenoceptor blockers in chronic obstructive pulmonary disease combined with chronic heart failure
原文传递
导出
摘要 慢性阻塞性肺疾病(COPD)常合并慢性心力衰竭,虽然肾上腺素β受体(β受体)阻滞药作为治疗慢性心力衰竭的基础药物,但长期被认为是治疗COPD的禁忌证。近来有研究报道,长期使用心脏选择性β受体阻滞药可降低COPD患者的死亡率并提高生活质量。本文就COPD患者中应用β受体阻滞药的研究进展进行综述。 Chronic obstructive pulmonary disease （COPD） is always combined with chronic heart failure. As the cornerstones of therapy for chronic heart failure, beta-adrenoceptor blockers （beta-blockers） are contra-indicated in COPD. Recent studies showed that chronic administration of cardioselective beta-blockers could decrease mortality and improve quality of life in COPD patients. This paper reviewes the research advancement and dispute of beta-blockers on patients with COPD.
作者 周俊 程齐俭 李敏
机构地区 上海交通大学医学院附属瑞金医院呼吸科
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2011年第11期815-819,共5页 Chinese Journal of New Drugs and Clinical Remedies
关键词 肾上腺素能Β受体拮抗剂 肺疾病 慢性阻塞性 慢性心力衰竭 药物疗法 adrenergic beta-antagonists pulmonary disease, chronic obstructive chronic heart failure drug therapy
分类号 R56 [医药卫生—呼吸系统]
  • 相关文献

参考文献33

  • 1MURRAY C J, LOPEZ AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study[J]. Lancet, 1997, 349(9064): 1498-1504.
  • 2HAWKINS NM, PETRIE MC, JHUND PS, et ol. Heart failure and chronic obstruction pulmonary disease: diagnostic pitfalls and epidemiolo~[J]. Eur Heart J Fail, 2009, 11 (2): 130-139.
  • 3HOGG K, SWEDBERG K, McMURRAY J. Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis[J]. J Am Coll Cardiol, 2004, 43 (3) : 317-327.
  • 4RUTTEN FH, CRAMER M J, GROBBEE DE, et al. Unrecog-nized heart failure in elderly patients with stable chronic obstructive pulmonary disease[J]. Eur Heart J, 2005, 26 (18) : 1887-1894.
  • 5RUTI'EN FH. 13-blockers and their mortalily benefits: under- prescribed in heart failure and chronic obstructive pulmonary disease[J]. Future Cardiol, 2011, 7 (1) : 43-53.
  • 6PADELETTI M, JELIC S, LEJEMTEL TiLl. Coexistent chronic obstructive puhnonary disease and heart failure in the elderly[J]. Int J Cardiol, 2008, 125(2) : 209-215.
  • 7HAWKINS NM, HUANG Z, PIEPER KS, et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial In- farction Trial (VALANT) [J]. EurJ Heart Fail, 2009, 11(3): 292-298.
  • 8BAKER JG. The selectivity of beta-adrenoceptor antagonists at the human betal, beta2 and beta3 adrenoceptors[J]. Br J Phar- mascol, 2005, 144(3): 317-322.
  • 9CALLAERTS-VEGH Z, EVANS KL, DUDEKULA N, et al. Effects of acute and chronic administration of beta-adrenoeeptor ligands on airway function in a murine model of asthma[J]. Proc Natl Acad Sci USA, 2004, 101 (14): 4948-4953.
  • 10LIN R, PENG H, NGUYEN LP, et al. Changes in beta 2- adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model[J]. Pulm Pharmacol Ther, 2008, 21 (1) : 115-124.

同被引文献57

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志（电子版）,2014,6(2):67-80. 被引量：2127
  • 2彭向前,李军,张鉴.多索茶碱注射液与地塞米松磷酸钠注射液配伍稳定性考察[J].中国药房,2005,16(18):1419-1420. 被引量：12
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量：8235
  • 4慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量：1796
  • 5SANKAR J, LODHA R, KABRA SK. Doxofylline: the next generation methylxanthine(J]. Indian J Pediatr, 2008, 75 (3) : 251- 254.
  • 6GARCIA-TALAVER I, AGUIRRE-JAIME A. COPD, normoxia, and early desaturation[J]. Chest, 2009, 135(3): 885-886.
  • 7SHUKLA D, CHAKRABORTY S, SINGH S, et al. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease[J]. Expert Opin Phar- macother, 2009, 10(14): 2343-2356.
  • 8Curkendall SM, Deluise C, Jones JK, et al. Cardiovascu- lar disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients [J]. Ann Epidemiol, 2006,16( 1 ) :63.
  • 9Katsura H, Yamada K, Wakabayashi R, et al. The impact of dyspnoea and leg fatigue during exercise on health-re- lated quality of life in patients with COPD[J]. Respirolo- gy, 2005,10(4) :485.
  • 10Salpeter S, Ormiston T, Salpeter E. Cardioselective beta- blockers for chronic obstructive pulmonary disease[J]. Co- chrane Database Syst Rev, 2005,19 (4) : CD003566.

引证文献7

二级引证文献35

中国新药与临床杂志
2011年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部